Aug 23, 2023 · Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side effects, interactions and indications.

Find patient medical information for Risedronate (Actonel, Atelvia) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Aug 7, 2024 · Atelvia is a brand (trade) name for delayed-release risedronate which may be used for the treatment or prevention of osteoporosis. Atelvia (risedronate) works by inhibiting osteoclasts which are responsible for breaking down and reabsorbing bone (by a process known as bone resorption).

COMMON BRAND NAME(S): Atelvia. What should I tell my care team before I take this medication? They need to know if you have any of these conditions: bleeding disorder; cancer; dental disease; difficulty swallowing; infection (fever, chills, cough, sore throat, pain or trouble passing urine) kidney disease; low levels of calcium in the blood

May 25, 2023 · What is Atelvia? Atelvia is a prescription medicine used to treat osteoporosis in women after menopause. It is not known how long Atelvia works for the treatment and prevention of osteoporosis. You should see your doctor regularly to determine if Atelvia is still right for you. Atelvia is not for use in children. Who should not take Atelvia?

Sep 17, 2024 · Atelvia package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Risedronate (Atelvia) is approved for the treatment of osteoporosis in postmenopausal women. Risedronate slows bone loss, increases bone density and reduces the risk of spine and non-spine fractures, including hip fractures.

Feb 16, 2020 · What is Atelvia used for? Atelvia is used to prevent or treat soft, brittle bones (osteoporosis). If you are allergic to Atelvia; any part of this medicine; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had.

Oct 20, 2023 · Atelvia is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, risedronate sodium has been shown to reduce the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [ see Clinical Studies (14.1) ] .

Atelvia (risedronate) is a bisphosphonate used to treat Paget’s disease of bone (osteitis deformans) and osteoporosis. Common side effects of Atelvia include headache, joint pain, diarrhea, abdominal pain, rash, indigestion, constipation, high …